Yigal Nochomovitz
Analyst
Citi
Equibles does not estimate personal net worth.
About Yigal Nochomovitz
Yigal Nochomovitz is recorded as Analyst at Citi. Yigal Nochomovitz has spoken on 4 earnings calls and 1 other investor event across 5 companies, most recently for Ligand Pharmaceuticals Inc on October 29, 2026. Those appearances were for Ligand Pharmaceuticals Inc (LGND), Ultragenyx Pharmaceutical Inc. (RARE), LENZ Therapeutics, Inc. (LENZ), Rigel Pharmaceuticals Inc (RIGL) and BeOne Medicines Ltd. (ONC). The companies whose calls Yigal Nochomovitz spoke on are classified in the Healthcare sector.
Yigal Nochomovitz on recent calls
“Just a question, one, on the risk model and how you think about, you know, probability-weighting success. Obviously, with the Pauvela Priority Review and the PDUFA, you know, you've passed a certain mark in terms of risk reduction.”
“I guess I just wanted to probe a little bit more, if I may, on the label language with respect to preserve neurodevelopmental function. You know, can you just drill into that a little bit more?”
“I'm curious on your decision with regard to the dosing, the 500 QD versus 500 BID. You know, pros and cons as far as which you would be more comfortable taking forward.”
Affiliation history
-
Citi
Analyst
Source not stated
Current